From: The PANGAEA study design – a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
Baseline
Follow up visits
Final visit (24 months)
UKNDS
X
at 12 months
EQ-5D, PRIMUS-A, PRIMUS-L
every 6 months
Compliance questionnaire
every 3 months
TSQM-9
Consumption of resources